相关实验视频
Updated: Jan 15, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
10.0K
p53:一个免疫生态系统操纵器
Zhigang Nian1,2,3, Yingchao Dou2,3, Haiming Wei1,2,3
1Division of Life Sciences and Medicine, Department of Geriatrics, First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
概括
瘤抑制基因p53中的突变会产生一种"免疫屏障网络",阻碍免疫治疗的有效性. 了解这种网络是开发新组合癌症治疗的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症遗传学 癌症遗传学
背景情况:
- 在癌症中,p53的突变很常见,导致其瘤抑制功能丧失.
- p53突变显著影响瘤免疫微环境,有助于免疫疗法耐药性.
研究的目的:
- 阐明p53突变建立免疫屏障网络的机制.
- 突出p53作为免疫疗法耐药性调解者的作用.
主要方法:
- 对p53突变及其对瘤免疫微环境的影响现有文献的综述.
- 分析p53突变如何调节机密体,免疫连接体,抗原呈现,新陈代谢和细胞外基质.
主要成果:
- 对于p53的突变,会产生一种
- 免疫屏障网络是一个免疫屏障网络.
- , , , 这是一个很好的方法.
- 这个网络涉及细胞因子,细胞外囊泡,免疫连接体,抗原呈现,瘤代谢和细胞外基质的调制.
- p53突变作为抗癌免疫疗法的关键媒介.
结论:
- 针对由p53突变建立的免疫屏障网络是组合免疫疗法的有希望的策略.
- 未来的研究应该调查突变的p53亚型,器官特异性,以及它们在新抗原生成和免疫抑制中的双重作用.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Negative Regulator Molecules
38.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K

